China Pharma Holdings Inc. (CPHI)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

China Pharma Holdings Inc. Stock (CPHI) Company Profile

China Pharma Holdings Inc.

Healthcare (1169)

86 898 6681 1730

No. 17, Jinpan Road, Second Floor, Haikou

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CPHI's Discussions on Twitter

Vergleichen Sie CPHI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CPHI China Pharma Holdings Inc.	0.208	4.00M	5.54M	-4.74M	-750.60K	-0.336
ZTS Zoetis Inc	160.46	71.85B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.08	45.58B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	14.06	44.58B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.74	19.18B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	128.60	13.67B	612.78M	-86.37M	-62.91M	-0.87

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2010-01-08	Eingeleitet	Rodman & Renshaw	Mkt Outperform

China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten

Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)

China Pharma Holdings Inc. (CPHI)

China Pharma Holdings Inc. Stock (CPHI) Company Profile

Vergleichen Sie CPHI mit anderen Aktien

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten

Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services - PR Newswire

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PR Newswire

InnoCare Pharma receives approval for CLL/SLL combination therapy trial in China - Yahoo

China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World

Is Pfizer Inc. (PFE) the Best Drug Stock to Buy Now? - Yahoo Finance

Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Yahoo Finance

U.S. investors, Big Pharma race to find new medicines in China - MSN

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - Quantisnow

China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World

Hong Kong Stock Exchange Companies List - Morningstar.com.au

Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace

China Pharma Holdings Inc (CPHI) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Post-Trade Analysis: China Pharma Holdings Inc (CPHI) Slides -7.63, Closing at 0.21 - The Dwinnex

Closing Bell Recap: International Paper Co (IP) Ends at 53.89, Reflecting a -3.47 Downturn - The Dwinnex

Big Pharma is staying quiet on Trump's China tariffs - Yahoo Finance

China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership - Simply Wall St

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat

China Universal Asset Management Co. Ltd. Acquires 8,018 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat

China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World

Pharmaceuticals Wholesale and Distribution Market to grow by USD 896.5 Billion (2024-2028), driven by rising global pharmaceutical sales, Report on how AI is redefining market landscapeTechnavio - Yahoo Finance

China NT Pharma Group to Hold Extraordinary General Meeting for New Share Subscription Approval - TipRanks

China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World

Ascentage Pharma Prices U.S. IPO At $17.25/ADS - RTTNews

Asia Hedge Funds Post Biggest Annual Returns Since the Pandemic - Bloomberg

Henlius Biotech shareholders reject take-private offer from China's Fosun - Reuters.com

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year - Yahoo Finance

‘The bar has risen’: China’s biotech gains push US companies to adapt - BioPharma Dive

Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update - Defense World

The top 10 biopharma M&A deals of 2024 - FiercePharma

Dry Eye Products Market Opportunities and Strategies to - GlobeNewswire

Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million - MSN

Barclays PLC Has $759,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World

China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com

China Pharma Holdings, Inc. Rescinds Securities Purchase Agreement - Defense World

PetVivo Holdings, Inc. to Make Investor Presentations - Defense World

Keen Vision Acquisition Extends Business Combination PeriodKeen Vision Acquisition Corporation (NASDAQ: KVAC) has recently filed a Form 8-K with the Securities and Exchange Commission, announcing the extension of its business combination period. T - Defense World

AmpliTech Group Enters Securities Purchase Agreement with Institutional InvestorsWASHINGTON, D.C., December 24, 2024 – AmpliTech Group, Inc. (NASDAQ: AMPG) disclosed today in an 8-K filing with the Securities and Exchange Commission that it has - Defense World

Blackboxstocks Inc. Dismisses Turner, Stone & Company as Independent Registered Public Accounting Firm; Engages Victor Mokuolo CPA PLLC as ReplacementOn December 20, 2024, Blackboxstocks Inc. (NASDAQ: BLBX) made significant changes in its a - Defense World

The Glimpse Group Announces Closing of $7.29 Million OfferingWASHINGTON, D.C., December 23, 2024 – The Glimpse Group, Inc. (NASDAQ:VRAR) disclosed the finalization of a registered direct offering on December 23, 2024. The undertaking involved a - Defense World

Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World

Analysts Set Celsius Holdings, Inc. (NASDAQ:CELH) Price Target at $50.28 - Defense World

China Pharma Holdings, Inc. Successfully Conducts Annual Stockholders’ Meeting - Defense World

GlycoMimetics Receives Extension Notice from Nasdaq Regarding Minimum Bid Price ComplianceOn December 19, 2024, GlycoMimetics, Inc. (NASDAQ: GLYC) disclosed in an 8-K filing with the Securities and Exchange Commission that it had received an e - Defense World

**Rhinebeck Bancorp Completes Balance Sheet Repositioning, Projects Earnings Growth** - Defense World

Wrap Technologies Reports Approval of Incentive Plan Amendment and Director Elections at Annual Meeting - Defense World

Financial Review: Autozi Internet Technology (Global) (NASDAQ:AZI) vs. Driven Brands (NASDAQ:DRVN) - Defense World

Aker BP ASA (OTCMKTS:AKRBF) Trading Down 1.7% – Here’s What Happened - Defense World

Edesa Biotech, Inc. (NASDAQ:EDSA) Short Interest Update - Defense World

Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CPHI

Rhinebeck Bancorp Completes Balance Sheet Repositioning, Projects Earnings Growth - Defense World